Neuro-cleansing peptides, including Selank, Dihexa, FGL, P21, Synapsin, and Cerebrolysin, play a pivotal role in promoting a healthy brain and offer a range of potential therapeutic benefits.
Selank:
Selank is a melanocortin-class peptide with similarities to ACTH/MSH analog tufstin. While it has traditionally been prescribed for anxiety and depression, it exhibits effectiveness in a variety of treatments, including immune modulation, anticoagulation, PTSD, ADHD, and metabolic syndromes. Selank offers anxiolytic, antidepressant, and immunomodulatory properties without the side effects associated with benzodiazepine tranquilizers. Moreover, it can help prevent weight gain and reduce cholesterol levels.
Dihexa:
Dihexa is an oligopeptide derived from angiotensin IV, with high binding affinity to hepatocyte growth factor (HGF) and its receptor c-Met. It is particularly relevant for improving cognitive function, memory, and synaptic plasticity. Clinical studies on Dihexa have demonstrated its potential in addressing traumatic brain injuries and neurodegenerative diseases, including Alzheimer’s.
FGL:
FGL, derived from neural cell adhesion molecule (NCAM), stimulates the production of new projections in developing neurons and enhances synaptic plasticity. It offers potential benefits, including neuroprotection, improved cognitive function, treatment for traumatic brain injuries, memory enhancement, and more. FGL is administered through a nasal spray and holds promise for various cognitive conditions.
P21:
P21 is a nootropic peptide derived from CNTF antibodies, primarily designed to aid in the treatment of Alzheimer’s and other neurodegenerative disorders. While there are no clinical trials, P21 has shown potential in promoting neurogenesis and synaptic growth.
Synapsin:
Synapsin is a peptide marker for the number of synapses in the brain, playing a vital role in synaptic transmission, neural development, and memory formation. It helps quantify synapses and is linked to NMDA receptor activity. Synapsin I and II contribute to neurotransmitter regulation, synaptic plasticity, and long-term potentiation.
Cerebrolysin:
Cerebrolysin is a neurotrophic factor-rich peptide formulation that resembles endogenous neurotrophins. It has demonstrated effectiveness in the treatment of neurodegenerative diseases, stroke, and traumatic brain injuries. Clinical trials have shown cognitive and behavioral improvements in Alzheimer’s disease and mild cognitive impairment patients, making it a candidate for further research in AD studies.
These neuro-cleansing peptides offer potential benefits for various brain-related conditions, and their mechanisms of action continue to be explored through ongoing research. If you seek more information about any specific peptide, do not hesitate to contact us for further insights and guidance.